Position in CYCN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,627
+$5,372 QoQ
Shares Held
3,135
-7.5% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 21 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYCN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. CYCN ranks #444 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in CYCN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,627 | 3,135 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,255 | 3,391 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $477 | 376 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $112 | 49 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $28,305 | 9,727 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $32,502 | 13,001 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $31,127 | 9,667 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $375 | 145 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,223 | 2,706 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,076 | 2,524 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,463 | 2,228 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $943 | 276 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $766 | 186 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,182 | 14,247 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,947 | 18,212 | Shares | Sole | 2023-02-08 | |
| 2022-03-31 | $4,045 | 3,645 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $10,880 | 3,544 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,053 | 270 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $13,061 | 4,682 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $16,575 | 5,417 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,473 | 407 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $40,069 | 6,780 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $37,528 | 14,162 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||